PARIS & BOSTON — Stilla Technologies, the multiplex digital PCR company, today announced it has raised €31.3 million in the form of €11.3 million of convertible bonds and €20 million in loan financing. In addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement and Eurazeo, […]
Leading R&D Cloud delivered triple-digit revenue growth and best-in-class dollar-based net expansion rate as total customer count increased 70% year over year SAN FRANCISCO — Benchling, pioneer of the R&D Cloud powering the biotechnology industry, has raised $100 million in Series F funding at a $6.1 billion valuation. The round was co-led by new investor […]
BOSTON — LabMinds Inc., an award-winning lab automation robotics company, announced it closed a $6.4M funding round in the third quarter. The funding round was completed by the company’s major investors including Waters Corporation and Red Deer Capital. This round also included funding from new investors. The funding will be used to drive commercialization of […]
ST. LOUIS, Mo. — Leinco Technologies, a specialty manufacturer of life science reagents used in drug discovery research and in vitro diagnostics applications, today announced a majority recapitalization of the company by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to […]
CHELMSFORD, Mass. — Brooks Automation, Inc. (Nasdaq: BRKS) announced at its investor day earlier today that it is changing its name to Azenta, Inc. and will begin trading on Nasdaq under the ticker symbol AZTA, effective at the open of market trading on December 1, 2021. This change follows the previously announced launch of the life sciences brand, Azenta Life Sciences. Following […]
Existing ZAGENO investors also participated in the financing CAMBRIDGE, Mass. and BERLIN — ZAGENO, a leading enterprise marketplace solution connecting eCommerce to life science, today announced that it completed a $60 million financing round led by General Catalyst and a large, vertically integrated, nonprofit healthcare organization. The new funding, which includes ongoing investments from Grazia […]
Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights LONDON & BOSTON — Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 […]
Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financing from Telegraph Hill Partners (“THP”), a life science venture capital and growth equity firm based in San Francisco, CA. The Company’s lead […]
Designed to bypass the oligo bottleneck in genomic research and development, the new platform will build on the success of DNA Script’s recently launched SYNTAX System using their innovative Enzymatic DNA Synthesis technology SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a leader in benchtop enzymatic DNA synthesis, today announced that the company has […]
NEW YORK — Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
